These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 8045490)
21. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
22. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma. Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221 [TBL] [Abstract][Full Text] [Related]
23. Usefulness of prophylactic transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Togo S; Tanaka K; Masui H; Matsuo K; Morioka D; Kurosawa H; Miura Y; Endo I; Sekido H; Shimada H Int Surg; 2005; 90(2):103-8. PubMed ID: 16119716 [TBL] [Abstract][Full Text] [Related]
24. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215 [TBL] [Abstract][Full Text] [Related]
25. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors. Lu W; Li Y; He X; Chen Y Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468 [TBL] [Abstract][Full Text] [Related]
26. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915 [TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma. Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090 [TBL] [Abstract][Full Text] [Related]
28. [The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma]. Zhang Z; Wu M; Liu Q Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):214-6. PubMed ID: 11776840 [TBL] [Abstract][Full Text] [Related]
29. [Intraportal infusion of 5-FU and lipiodol-aclarubicin after hepatic resection for colorectal liver metastasis]. Ambiru S; Miyazaki M; Ito H; Kaiho T; Ando K; Hayashi S; Nakajima N Nihon Geka Gakkai Zasshi; 1995 Mar; 96(3):145-52. PubMed ID: 7731455 [TBL] [Abstract][Full Text] [Related]
30. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma. Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925 [TBL] [Abstract][Full Text] [Related]
31. [Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy]. Takanishi K; Matsumoto J; Minami T Gan To Kagaku Ryoho; 1999 Oct; 26(12):1747-51. PubMed ID: 10560386 [TBL] [Abstract][Full Text] [Related]
32. [A case of recurrent hepatocellular carcinoma successfully treated by arterial chemoembolization in combination with local hyperthermia]. Kawano K; Tada I; Suzuki K; Nakashima K; Yoshida T; Mitarai Y; Kim YI; Kobayashi M Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2957-60. PubMed ID: 2551234 [TBL] [Abstract][Full Text] [Related]
33. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection]. Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905 [TBL] [Abstract][Full Text] [Related]
34. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis. Wen J; Shen WL; Yang SH Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580 [TBL] [Abstract][Full Text] [Related]
35. Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma. Ochiai T; Sonoyama T; Hironaka T; Yamagishi H Hepatogastroenterology; 2003; 50(51):750-5. PubMed ID: 12828078 [TBL] [Abstract][Full Text] [Related]
36. [Usefulness of subcutaneously implanted reservoir for postoperative therapy in hepatocellular carcinoma and liver metastases of colorectal carcinoma]. Kajikawa S; Horigome N; Hanasaki K; Adachi W; Kinosita T; Sodeyama H; Kuroda T; Iida F Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2774-7. PubMed ID: 2551221 [TBL] [Abstract][Full Text] [Related]
37. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y; Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600 [TBL] [Abstract][Full Text] [Related]
38. Multimodality management of hepatocellular carcinoma larger than 10 cm. Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406 [TBL] [Abstract][Full Text] [Related]
39. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065 [TBL] [Abstract][Full Text] [Related]
40. [Results of SMANCS/Lipiodol injection therapy for multiple intrahepatic recurrence of hepatocellular carcinoma]. Nakaba H; Hashimoto T; Sunada S; Akamatsu D; Ito A; Teramoto S; Ohara S; Katayama S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():46-50. PubMed ID: 9512687 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]